Showing results (91-100 of 354) with videos related to

Sort By:
Pageof 36
Molecular Cancer Therapeutics|October 8, 2011
Akt/mTOR counteract the antitumor activities of cixutumumab, an anti-insulin-like growth factor I receptor monoclonal antibodyDong Hoon Shin, Hye-Young Min, Adel K El-Naggar, et al.
Cancer|October 1, 2008
Genetic variations in cell-cycle pathway and the risk of oral premalignant lesionsYuanqing Ye, Scott M Lippman, J Jack Lee, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 31, 2024
Deep Learning Artificial Intelligence Predicts Homologous Recombination Deficiency and Platinum Response From Histologic SlidesErik N Bergstrom, Ammal Abbasi, Marcos Díaz-Gay, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 17, 2006
The role of prevention in oncology practice: results from a 2004 survey of American Society of Clinical Oncology members, Patricia A Ganz, Lorna Kwan, et al.
International Journal of Oncology|March 11, 2004
Human telomerase reverse transcriptase mRNA is highly expressed in normal breast tissues and down-regulated in ductal carcinoma in situJinsong Liu, Atac Baykal, Kar-Ming Fung, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 10, 2004
Differential peroxisome proliferator-activated receptor-gamma isoform expression and agonist effects in normal and malignant prostate cellsVemparala Subbarayan, Anita L Sabichi, Jeri Kim, et al.
Nature|April 12, 2023
Chromosomal fragile site breakage by EBV-encoded EBNA1 at clustered repeatsJulia Su Zhou Li, Ammal Abbasi, Dong Hyun Kim, et al.
Molecular Carcinogenesis|October 24, 2009
Genetic variation in MicroRNA genes and risk of oral premalignant lesionsJessica Clague, Scott M Lippman, Hushan Yang, et al.
Pageof 36